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Introduction

35
Therapeutic hypothermia is beneficial for patients with acute myocardial 36 infarction or post cardiac arrest syndrome [1] [2] [3] [4] [5] . Several drugs such as propofol, 37 midazolam, or dexmedetomidine have been used during hypothermia to cause a sedative 38 action or negate the complications of hypothermia [5, 6] . However, the pharmacokinetics 39 of drugs used during therapeutic hypothermia have been shown to be altered [7] [8] [9] . We need 40 to identify the factors affecting the disposition of a drug to optimize medication. We could differ with the disposition route and intrinsic clearance of these drugs [10, 11] .
45
Despite of necessity to determine the individual factors affecting drug disposition for 46 prediction the pharmacokinetics during hypothermia, it has not been clarified. In this 47 study, we tried to evaluate the effect of temperature on drug disposition by focusing on 48 the hepatic disposition.
49
In this study, we chose 4-nitrophenol (4NP) as a model compound metabolized in the liver by CYP2E1 [12, 13] . We thought we could evaluate the effect of hypothermia 51 on a drug disposition metabolized by CYP2E1 which plays a major role in the metabolism 52 4 of several drugs used during hypothermia such as acetaminophen, isoflurane, isoniazid,
53
and theophylline [14] [15] [16] [17] [18] .
54
In the present study, we examined the effect of low temperature on the CYP2E1 by Eq.1
where v is the eliminate velocity, C0 and C15 represent the concentration of 4NP 86 at 0 and 15 min, respectively, and V is the incubation volume (1 mL).
87
The Michaelis constant (Km) and maximum eliminate velocity (Vmax) were Liver perfusion study 95 Male Wistar rat liver was perfused in situ as described previously [11] . After a The drug solution (20 mg/mL x 0.1 mL) was injected into the right femoral vein.
114
After administration of the drug solution, blood was collected at the selected times from 115 the heparinized cannula inserted into the femoral artery until 50 min. Blood was 116 centrifuged at 15000 rpm for 5 min.
117
Moment parameters (AUCp and MRTp) were calculated by numerical integration 118 using a linear trapezoidal formula and extrapolation to infinite time based on a 119 monoexponential equation [19] . Change in the hepatic extraction ratio at low temperatures in the rat liver perfusion system we ran the liver perfusion study under a constant flow rate and protein-free conditions. to 4NP uptake into the liver [23] .
183
Concerning Oat activity under hypothermic conditions, a decrease in the uptake 184 of phenolsulfonphthalein into the liver via Oat was suggested in our previous study [11] .
185
Furthermore, we showed a reduction in CYP2E1 activity at low temperatures in this study,
186
and this alteration may have also had an effect on the Eh of 4NP. Thus, the reduction in
187
CYP2E1 and Oat activity could cause changes in the Eh of 4NP under hypothermic 188 conditions.
189
As the next step, we evaluated the pharmacokinetics of 4NP in rats to identify 190 how alterations in the hepatic disposition affected the pharmacokinetics of 4NP in rats.
191
As illustrated in Fig.2 , the plasma concentration of 4NP was significantly increased at (Table I ). In general, the hepatic clearance of a drug depends on hepatic blood flow and
194
Eh. It has been reported that the blood flow was reduced under hypothermia [24] .
195
Moreover, we determined the protein binding ratio of 4NP with BSA by equilibrium 196 dialysis method and it was slightly increased at 28 o C compared to 37 o C (data not shown).
197
These results suggest that the reduction of CLtot might be caused by reduction of Eh,
198
hepatic blood flow or unbound fraction of 4NP.
199
Conclusion
200
We showed that the elimination velocity from homogenate and Eh of 4NP were 201 decreased under hypothermic conditions and that these alterations could affect the 202 CLtot: total body clearance.
213
The AUCp, MRTp, and CLtot represent the mean ± S.E. of at least four experiments. 
